Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial assessing the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo in adults with major depressive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED